Not Enough Evidence to Use BMP Off-Label, Panel Says
BALTIMORE -- A Medicare advisory committee has voted that there is not enough evidence to warrant off-label use of recombinant human bone morphogenetic protein, or BMP, for bone surgery.
Sep 22, 2010